perflubron has been researched along with Cancer of Pancreas in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Y; Han, X; Jiang, L; Liu, M; Niu, D; Song, X; Wang, R; Yao, Y; Yu, Q | 1 |
| Bridal, SL; Chaminade, P; Díaz-López, R; Fattal, E; Jaillard, D; Libong, D; Marsaud, V; Nicolas, V; Santin, M; Tsapis, N; Vauthier, C | 1 |
2 other study(ies) available for perflubron and Cancer of Pancreas
| Article | Year |
|---|---|
CD133-Targeted Hybrid Nanovesicles for Fluorescent/Ultrasonic Imaging-Guided HIFU Pancreatic Cancer Therapy.
Topics: AC133 Antigen; Cell Line, Tumor; Coloring Agents; Humans; Neoplastic Stem Cells; Pancreatic Neoplasms; Tumor Microenvironment; Ultrasonics; Ultrasonography | 2023 |
The performance of PEGylated nanocapsules of perfluorooctyl bromide as an ultrasound contrast agent.
Topics: Animals; Chromatography; Complement Activation; Complement C3; Contrast Media; Electrophoresis, Gel, Two-Dimensional; Fluorocarbons; Humans; Hydrocarbons, Brominated; Hydrophobic and Hydrophilic Interactions; Mice; Nanocapsules; Pancreatic Neoplasms; Particle Size; Phosphatidylethanolamines; Polyethylene Glycols; Surface Properties; Ultrasonics; Ultrasonography | 2010 |